Ginkgo biloba extracts and cancer: a research area in its infancy

Francis V DeFeudis1, Vassilios Papadopoulos, Katy Drieu

  • 1Institute for BioScience, 153 West Main Street, Westboro, MA, USA. defeudis@gis.net

Insights

Ginkgo biloba leaf extracts show anticancer potential through antioxidant and gene-regulatory actions. These effects, driven by flavonoids and terpenoids, may inhibit cancer cell proliferation and protect against DNA damage.

Area of Science:

  • Phytochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Ginkgo biloba leaf extracts possess antioxidant and anti-lipoperoxidative properties attributed to flavonoid and terpenoid compounds.
  • Extracts exhibit anti-angiogenic activity, potentially via antioxidant effects and inhibition of nitric oxide synthase.
  • Previous research suggests potential chemopreventive roles for Ginkgo biloba.

Purpose of the Study:

  • To investigate the anticancer (chemopreventive) properties of Ginkgo biloba leaf extracts.
  • To elucidate the molecular mechanisms underlying the anticancer effects, including antioxidant, anti-angiogenic, and gene-regulatory actions.
  • To assess the role of specific constituents like ginkgolide B in cancer cell inhibition.

Main Methods:

  • Utilized molecular, cellular, and whole animal models.
  • Performed cDNA microarray analyses to study gene expression changes in cancer cells.
  • Assessed inhibition of proliferation in human breast cancer cell lines and xenografts.
  • Evaluated effects on radiation-induced clastogenic factors and UV-induced oxidative stress in humans.

Main Results:

  • Ginkgo biloba extract and ginkgolide B inhibited proliferation of aggressive human breast cancer cells and xenografts.
  • Gene expression analysis revealed altered regulation of cell proliferation, differentiation, and apoptosis.
  • Extracts demonstrated adaptive transcriptional responses in bladder cancer cells, enhancing antioxidant status and inhibiting DNA damage.
  • In humans, extracts reduced radiation-induced clastogenic factors and UV-induced oxidative stress.

Conclusions:

  • Ginkgo biloba leaf extracts exhibit multifaceted anticancer properties, including antioxidant, anti-angiogenic, and gene-regulatory effects.
  • Flavonoid and terpenoid constituents likely act synergistically to inhibit carcinogenesis-related processes.
  • The findings support the potential of Ginkgo biloba extracts as a chemopreventive agent, with total extracts potentially offering optimal efficacy.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...